Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Low and Intermediate Risk Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04100811
What this trial is testing

Identification of Clinically Insignificant or Significant Prostate Cancer With the miR Scientific Sentinel™ Platform

Who this might be right for
Prostate Cancer
miR Scientific LLC 2,019
Not applicableUnknownNCT05584787
What this trial is testing

Transperineal Laser Ablation for Low- and Intermediate Risk Prostate Cancer: a Single Cohort Analysis

Who this might be right for
Prostate Cancer
San Carlo di Nancy Hospital 20
Not applicableStudy completedNCT01423474
What this trial is testing

Prostate Accurately Targeted Radiotherapy Investigation of Overall Treatment Time

Who this might be right for
Prostatic Neoplasms
CancerCare Manitoba 152
Testing effectiveness (Phase 2)UnknownNCT02077335
What this trial is testing

Study of High-dose Rate (HDR) Monotherapy for Low and Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
CSSS de Gatineau 50
Not applicableStudy completedNCT00977860
What this trial is testing

Hypofractionated SBRT For Prostate Cancer

Who this might be right for
Prostate Cancer
Adam Olson 163
Testing effectiveness (Phase 2)UnknownNCT01890096
What this trial is testing

A Phase II Trial of High Dose-Rate Brachytherapy as Monotherapy in Low and Intermediate Risk Prostate Cancer

Who this might be right for
Carcinoma of the Prostate
Sunnybrook Health Sciences Centre 174
Not applicableActive Not RecruitingNCT01936883
What this trial is testing

Improving Quality of Life After Prostate Brachytherapy: a Comparison of HDR and LDR Brachytherapy

Who this might be right for
Prostate Cancer
British Columbia Cancer Agency 195
Not applicableStudy completedNCT00643994
What this trial is testing

CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution

Who this might be right for
Prostate CancerProstatic CancerProstate Neoplasms+2 more
Accuray Incorporated 379
Testing effectiveness (Phase 2)UnknownNCT02165020
What this trial is testing

Hyaluronic Acid for Hypofractionated Prostate Radiotherapy

Who this might be right for
Prostate Cancer
Hospices Civils de Lyon 36
Testing effectiveness (Phase 2)Ended earlyNCT04264208
What this trial is testing

HDR Brachytherapy 68-Ga-RM2 PET, 68-Ga-PSMA-11 PET &Multi Parametric MRI in Prostate Cancer

Who this might be right for
Prostate Cancer
Andrei Iagaru 4
Not applicableLooking for participantsNCT06117059
What this trial is testing

The PRECISION Study: 3 Fractions of Prostate SBRT and RayPilot HypoCath Image Guidance

Who this might be right for
Localized Prostate CancerLow Risk Prostate CancerIntermediate Risk Prostate Cancer
NHS Lothian 100
Large-scale testing (Phase 3)Study completedNCT04627896
What this trial is testing

Targeted Microwave Focal Therapy

Who this might be right for
Prostate Cancer Stage I
A.O.U. Città della Salute e della Scienza 11
Testing effectiveness (Phase 2)UnknownNCT02342054
What this trial is testing

Single Fraction Real-time High-Dose-Rate Brachytherapy in Patients With Low and Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Hospital de Cruces 49
Large-scale testing (Phase 3)Active Not RecruitingNCT05050084
What this trial is testing

Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial

Who this might be right for
Prostate Adenocarcinoma
NRG Oncology 2,050
Not applicableLooking for participantsNCT07339943
What this trial is testing

Micro-ultrasound-Guided Focal Laser Ablation for Intermediate-Risk Prostate Cancer: Safety & Effectiveness

Who this might be right for
Prostate Cancer (Adenocarcinoma)Low and Intermediate Risk Prostate Cancer
University Health Network, Toronto 7
Not applicableEnded earlyNCT00619515
What this trial is testing

Stereotactic Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Case Comprehensive Cancer Center 73
Not applicableNot Yet RecruitingNCT07526675
What this trial is testing

Concomitant Trans-Perineal Prostate Biopsy and Ablation (Bioblation) for Prostate Cancer

Who this might be right for
Prostate CancerLower Urinary Tract Symptoms (LUTS)Benign Prostatic Hyperplasia
Benha University 30
Testing effectiveness (Phase 2)WithdrawnNCT04569461
What this trial is testing

Trimodality Approach of Low Dose iOnizing Radiation With or Without Neoadjuvant Pembrolizumab and Prostatectomy for Men With Intermediate/High Risk Prostate Cancer (TALON)

Who this might be right for
Prostate Cancer
Duke University
Not applicableStudy completedNCT03790995
What this trial is testing

Functional Outcomes and QoL in Patients With High Versus Low and Intermediate Risk Prostate Cancer Treated by RARP

Who this might be right for
Prostate CancerQuality of LifeErectile Function+1 more
KU Leuven 9,235
Not applicableUnknownNCT04656678
What this trial is testing

Focal US-guided Cryo-ablation Using DynaCAD / UroNAV Preplanning / Guidance of Intermediate Risk Prostate Cancer

Who this might be right for
Prostate CancerProstate Disease
Northwell Health 200
Next Page